Royalty Pharma Plc (RPRX)
45.19
+0.39
(+0.87%)
USD |
NASDAQ |
Feb 13, 16:00
45.20
+0.01
(+0.02%)
After-Hours: 20:00
Royalty Pharma EPS Diluted (Quarterly) : 0.4992 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Denali Therapeutics, Inc. | -0.736 |
| PTC Therapeutics, Inc. | 0.195 |
| Veru, Inc. | -0.2625 |
| Incyte Corp. | 1.462 |
| Vertex Pharmaceuticals, Inc. | 4.65 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 356.00M |
| Revenue (Quarterly) | 622.00M |
| Total Expenses (Quarterly) | 408.00M |
| Enterprise Value | 30.93B |
| Gross Profit Margin (Quarterly) | 99.81% |
| Profit Margin (Quarterly) | 57.23% |
| Earnings Yield | 3.94% |
| Operating Earnings Yield | 6.48% |
| Normalized Earnings Yield | 3.819 |